Abstract:Deep vein thrombosis (DVT) and pulmonary embolism (PE) are distinct but related aspects of the same dynamic disease process known as venous thromboembolism (VTE). An estimated 200,000 new cases occur in the United States every year, including 94,000 with PE, resulting in an incidence of 23 per 100,000 patients per year-cases. Without treatment, pulmonary embolism is associated with a mortality rate of approximately 30%, causing nearly 50,000 deaths per year. Moreover, based on post-mortem studies, two-thirds of the patients with pulmonary emboli remain undiagnosed. Clinically, PE may present as (1) isolated dyspnea, (2) pleuritic pain and/or hemoptysis, and (3) circulatory collapse. However, clinical history and examination can be notoriously misleading in reaching a diagnosis. A number of acquired etiologic risk factors (predispositions) are associated with a tendency to develop VTE. These include increasing age, immobilization, surgery, trauma, hospital or nursing home confinement, malignancy, neurologic disease with extremity paresis, as well as certain types of oral contraception and hormone replacement therapy. In addition, a variety of genetic risk factors, such as factor V Leiden, protein S or C deficiency have also been identified. However, in at least half of the instances, no predisposing factors can be identified (idiopathic PE). In the majority of cases thromboemboli originate in the deep veins of the calf or pelvis. The pathogenic conditions for VTE comprise a triad of factors and include (1) venous stasis, (2) hypercoagulable states, and (3) vascular endothelium injury. Occlusion of pulmonary arteries has variable and transient clinical and pathophysiologic consequences, involving both mechanical and reflex effects of vascular occlusion with a consecutive perfusion defect as well as the release of vasoactive and other inflammatory mediators. The objectives of this article are to present an overview of the etiologic and pathogenic factors promoting VTE as well as the pathophysiologic and inflammatory processes following PE.

[Pulmonary embolism suspicion in a young female patient with the Paget-von Schrötter syndrome]

Clinical analysis of acute pulmonary embolism in 49 cases

Cardiac Arrest Due to Pulmonary Embolism Without Clinical Features of Deep Vein Thrombosis in a Young Female: A Rare Presentation of May-Thurner Syndrome

Exercise-induced venous thrombosis of the upper extremity: A case report

Beyond an upper extremity clot: A case report of paget-schroetter syndrome

Deep Vein Thrombosis in Upper Limb in a Weightlifter

Acute bilateral pulmonary embolism in a 21-year-old: is May-Thurner syndrome in our differential?

The Incidence of Pulmonary Embolism in Patients with Combined Lower Extremity Deep Venous Thrombosis and Iliac Vein Compression Syndrome

Familiar Disposition of May–Thurner Syndrome—A Case Series

Upper extremity deep vein thrombosis (Paget-Schroetter syndrome) after surfing: a case report

Effort thrombosis (Paget-Schroetter syndrome) in a 16-year-old male

Epidemiology, Etiology, and Pathophysiology of Pulmonary Embolism

[Fatal outcome of bilateral pulmonary embolism combined with ascending varicophlebitis of the lower limb: case report]

Paget-Schroetter Syndrome in a Patient With Posterior Shoulder Subluxation: A Case Report

Concurrent Pulmonary Thrombosis with Systemic Embolism: A Case Report

Paget-Schroetter Syndrome: A Case of a Young Weightlifter

Principle Mechanisms Underlying Venous Thromboembolism: Epidemiology, Risk Factors, Pathophysiology and Pathogenesis

Risk Factors Leading to Pulmonary Embolism in Patients of Lower Extremity Deep Vein Thrombosis with Iliac Vein Compression

Clinical Presentation and Risk Stratification of Pulmonary Embolism

Thrombus risk versus bleeding risk: a clinical conundrum

Septic Pulmonary Embolism With Deep Vein Thrombosis and Bilateral Pleural Effusion